Cellix Ltd logo

Cellix Ltd

Contact Details

Skip to Navigation |  Skip to Content |  Skip to Login
Start of page content
Back to Navigation

Immunology

Integrins are protein receptors that connect the extracellular environment with intracellular signaling events in a cell. Integrins are important for normal development and function, but are also involved in the pathogenesis of diseases including cancer, autoimmunity, rheumatoid arthritis, crohn's disease and heart disease. It is important to understand the normal adhesion profiles of leukocytes so as to identify their role in disease states.                                                                                                    

Inflammation:

Role played by key adhesion molecules in inflammatory diseases

Inflammation is an adaptive response that is triggered by noxious stimuli and conditions, such as infection and tissue injury.

In this study we present data on the adhesion profiles of monocytes and PBMCs on a range of adhesion molecules and on endothelial cells, analyzing the role of these proteins and other chemokines, which are involved in various stages of inflammation and leukocyte trafficking, under physiological flow conditions using Cellix’s VenaFluxTM microfluidic platform.

Statins are cholesterol-reducing drugs that have become a cornerstone of primary and secondary prevention of cardiovascular disease. In recent years, pleiotropic effects of statins have been highlighted including immunomodulatory properties in conditions as diverse as rheumatoid arthritis and COPD. Statins exert these effects on the inflammatory responses in part through modulating lymphocyte adhesion to endothelial cells.                          

Download Immunology Application Note (I200) NEW!!! 


      
  
Rolling of THP1 monocytes subjected to 0.5 dyne cm² on E-selectin

Immunomodulation:

Screening statin drugs for their potential treatment of sepsis

Sepsis continues to be an increasingly frequent and acute medical problem in critically ill patients in the intensive care unit. Experimental evidence in animals has indicated that statins may prevent sepsis and modulate its severity. Statins are proposed to inhibit the binding of T-cells to ICAM-1 on endothelial cells.

Using Cellix's VenaFlux Platform, the adhesion profile of statin-treated T-cells from a mixed-sepsis model was assessed.

Download Immunology Application Note (I100).




Register/Login

Not Registered? Sign Up Now

Register for My Cellix

Bottom Navigation